Detail Information of Genetic Polymorphisms
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0456 Transporter Info | ||||
| Gene Name | SLC6A4 | ||||
| Protein Name | Sodium-dependent serotonin transporter | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Genetic Polymorphisms of DT (GPD) | |||||
| Genetic Polymorphism | rs25531 | ||||
| Site of GPD | chr17:30237328 (GRCh38.p12) | ||||
| GPD Type | SNP | ||||
| Allele(s) in dbSNP | T>C | ||||
| Minor Allele Frequency | C=0.1376/689 (Global) | ||||
| Allele C | Click to Show/Hide the Full List of Affected Drugs: 4 Drugs in Total | ||||
| Citalopram | Drug Info | Dementia | Correlated with the increased likelihood of side effects in patients (compare with Allele T) | [ 1] | |
| Citalopram | Drug Info | Depression | Irrelevant to the drug response in patients (compare with Allele T) | [ 2] | |
| Citalopram | Drug Info | Major Depressive Disorder | Irrelevant to the increased likelihood of remission in patients (compare with Allele T) | [ 3] | |
| Fluoxetine | Drug Info | Major Depressive Disorder | Irrelevant to the drug response in patients (compare with Allele T) | [ 4] | |
| Genotypes CC + CT | Click to Show/Hide the Full List of Affected Drugs: 1 Drugs in Total | ||||
| Fluoxetine | Drug Info | Major Depressive Disorder | Correlated with the increased reduced drug response risk in patients (compare with Genotype TT) | [ 5] | |
| Genetic Polymorphism | rs57098334 | ||||
| Site of GPD | chr17:30221569-30221577 (GRCh38.p12) | ||||
| GPD Type | Indel Insertion and Deletion | ||||
| Allele(s) in dbSNP | ins(AGCCCACCC)8AGCCCACC / ins(AGCCCACCC)9AGCCCACC / ins(AGCCCACCC)11AGCCCACC | ||||
| (AGCCCACCC)12 | Click to Show/Hide the Full List of Affected Drugs: 1 Drugs in Total | ||||
| Sertraline | Drug Info | Major Depressive Disorder | Irrelevant to the drug response in patients (compare with allele (AGCCCACCC)9) | [ 6] | |
| References | |||||
| 1 | Serotonin transporter triallelic genotype and response to citalopram and risperidone in dementia with behavioral symptoms. Int Clin Psychopharmacol. 2010 Jan;25(1):37-45. | ||||
| 2 | SLC6A4 variation and citalopram response. Am J Med Genet B Neuropsychiatr Genet. 2009 Apr 5;150B(3):341-51. | ||||
| 3 | SLC6A4 polymorphisms and age of onset in late-life depression on treatment outcomes with citalopram: a Sequenced Treatment Alternatives to Relieve Depression (STAR*D) report. Am J Geriatr Psychiatry. 2014 Nov;22(11):1140-8. | ||||
| 4 | The role of clinical variables, neuropsychological performance and SLC6A4 and COMT gene polymorphisms on the prediction of early response to fluoxetine in major depressive disorder. J Affect Disord. 2010 Dec;127(1-3):343-51. | ||||
| 5 | Sequence analysis of the serotonin transporter and associations with antidepressant response. Biol Psychiatry. 2005 Sep 1;58(5):374-81. | ||||
| 6 | Serotonin transporter gene polymorphisms and sertraline response in major depression patients. Genet Test. 2008 Jun;12(2):225-31. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.